Johnson Matthey Escapes Shire's Vyvanse Patent Suit

By Kelly Knaub ( January 21, 2016, 10:40 PM EST) -- A New Jersey federal judge Thursday released Johnson Matthey Inc. from Shire LLC's suit accusing it of infringing patents on attention deficit hyperactivity disorder drug Vyvanse, nearly four months after the Federal Circuit ruled Johnson Matthey could not be held liable for supplying generics makers with ingredients....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!